MarketsJul 30, 20256 min read

Top 3 Capex — 2025

Three companies investing aggressively today whose operating leverage could meaningfully play out over FY26 and beyond.

Top 3 Capex — 2025 — cover image

1) Deepak Fertilizers

Leading Indian chemical and fertiliser producer with three main verticals: Mining (TAN), Crop Nutrition (CNB), and Industrial Chemicals (IC). ₹4,500 crore capex programme underway.

2) HCG

India's largest pan-India oncology hospital chain. FY25–FY26 capex guidance of ₹275–280 crore per annum.

3) SRF

FY26 capex for current and future projects: ₹1,500–2,000 crore range across specialty chemicals, fluorochemicals, and packaging films.

Recent posts

See all blogs →
3 Interesting Hospital Plays — cover image
Aug 6, 20256 min read

3 Interesting Hospital Plays

A deep-dive on three hospital plays — Rainbow Children's Medicare, HCG, and KIMS — across paediatrics, oncology and pan-India multispecialty.

Windlas Biotech Ltd — The Pharma Beneficiary — cover image
Jul 2, 20256 min read

Windlas Biotech Ltd — The Pharma Beneficiary

A focused look at one of India's leading CDMO operators in the generic pharma space, and why it sits at the intersection of multiple structural tailwinds.